|Infectious Diseases Summit|
Antiviral Drugs Research & Development
Vaccines Research & Development
Anti-Infectives Partnering & Deal-Making
We are pleased to invite you to attend GTCbio’s Infectious Diseases Summit, which will take place July 13-14, 2017 in Baltimore, MD. This event seeks to provide a forum for leaders to get the most comprehensive and wide-reaching perspective on issues, challenges, and advances in the field. Recent developments in the space has signaled the landscape of infectious diseases is shifting: Why is there a renewed interest in this field? What will it mean for biotech companies, government agencies, and other players? This Summit seeks to highlight all stages of the field, from research and novel therapeutics, to commercialization aspects and market activity.
The Summit begins with the Plenary Session on Responding to Emerging Infectious Diseases on the Global Stage and disperses into the following three conferences:
- Vaccines for Infectious Diseases-Old & New Challenges
- Next-Generation Vaccine Technologies
- Enhancing Immunity at Both Ends of the Age Spectrum
- Panel: Clinical Trial Design During Epidemics
- Non-Traditional Approaches and Technologies in Anti-Infectives
- Regulatory Considerations for Drug Development
- Economic Drivers Moving Drug Development Forward
- Panel: Funding & Partnering with US Government Agencies
- Panel: Pricing and P&T Committee’s Role in Determining Novel Antibiotic Usage
- Panel: Pushing and Pulling-What Incentives Help Spark Innovation in Antibiotic Drug Discovery and Development?
- Respiratory Viral Infections: Current Landscape and Emerging Drugs
- Blood Borne Pathogens: New Frontiers in Research and Drug Development
- Challenges in Clinical Study Design and Considerations
- Panel: New Approaches to Antiviral Development
The summit will end with a General Session on Public/Private Partnerships in Support of Global Health.
In recent years, the field of infectious diseases has faced repeated challenges, and areas such as pricing and reimbursement, regulatory, and the discovery of novel antibiotics have yet to be overcome. Colleagues from academia, industry, and government will gather at the interface of infectious diseases drug development to address current issues and find solutions to move the field forward.
We hope to see you in Maryland!
The 2017 Advisory Committee
Amber Kempf at 626-256-6405 x110 or amber.kempf [at] gtcbio.com
For more information on Media Relations, please contact:
Jennifer Chu at 626-256-6405 x105 or jennifer.chu [at] gtcbio.com